Search Within

Ronald A Ghossein

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (76)
  2. Meeting Abstract (27)
  3. Editorial (1)
  4. Guidelines (1)
Groups
  1. Department of Pathology and Laboratory Medicine (105)
  2. GSK Faculty (105)
  3. Human Oncology and Pathogenesis Program (105)
  4. Department of Medicine (90)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (84)
  6. Division of Subspecialty Medicine (84)

More Groups

People
  1. James Fagin (84)
  2. Robert Tuttle (36)
  3. Jeffrey Knauf (34)
  4. Ian Ganly (26)
  5. Bin Xu (25)
  6. Alan Ho (21)

More People

Years
  1. 2025 (3)
  2. 2024 (6)
  3. 2023 (5)
  4. 2022 (14)
  5. 2021 (3)
  6. 2020 (15)

More Years

Publications
  1. Modern Pathology (12)
  2. Nature Communications (10)
  3. Thyroid (10)
  4. Cancer Research (8)
  5. Journal of Clinical Endocrinology and Metabolism (8)
  6. Laboratory Investigation (7)

More Publications

Publishers
  1. Nature Publishing Group (20)
  2. American Association for Cancer Research (17)
  3. Nature Research (12)
  4. Mary Ann Liebert, Inc (10)
  5. Oxford University Press (9)
  6. Springer (7)

More Publishers

Results (105)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Immunohistochemical detection of mutated BRAF V600E supports the clonal origin of BRAF-induced thyroid cancers along the spectrum of disease progression
    Journal Article

    Ghossein, R. A.; Katabi, N.; Fagin, J. A.
    Journal of Clinical Endocrinology and Metabolism (2013)

    Fulltext@MSK | Save
  • Clinical outcomes and molecular profile of differentiated thyroid cancers with radioiodine-avid distant metastases
    Journal Article

    Sabra, M. M.; Domínguez, J. M.; Grewal, R. K.; Larson, S. M.; Ghossein, R. A.; Tuttle, R. M.; Fagin, J. A.
    Journal of Clinical Endocrinology and Metabolism (2013)

    Fulltext@MSK | Save
  • Relief of feedback inhibition of HER3 transcription by RAF and MEK inhibitors attenuates their antitumor effects in BRAF -mutant thyroid carcinomas
    Journal Article

    Montero-Conde, C.; Ruiz-Llorente, S.; Domínguez, J. M.; Knauf, J. A.; Viale, A.; Sherman, E. J.; Ryder, M.; Ghossein, R. A.; Rosen, N.; Fagin, J. A.
    Cancer Discovery (2013)

    Fulltext@MSK | Save
  • Genomic dissection of hurthle cell carcinoma reveals a unique class of thyroid malignancy
    Journal Article

    Ganly, I.; Filho, J. R.; Eng, S.; Ghossein, R.; Morris, L. G. T.; Liang, Y.; Socci, N.; Kannan, K.; Mo, Q.; Fagin, J. A.; more...
    Journal of Clinical Endocrinology and Metabolism (2013)

    Fulltext@MSK | Save
  • Immunohistochemical (IHC) detection of mutated brafV600E along the spectrum of thyroid carcinoma (TC) progression
    Meeting Abstract

    Ghossein, R.; Ricarte, J.; Knauf, J.; Rivera, M.; Fagin, J.
    Modern Pathology (2013)

    Fulltext@MSK | Save
  • Immunohistochemical (IHC) detection of mutated brafV600E along the spectrum of thyroid carcinoma (TC) progression
    Meeting Abstract

    Ghossein, R.; Ricarte, J.; Knauf, J.; Rivera, M.; Fagin, J.
    Laboratory Investigation (2013)

    Fulltext@MSK | Save
  • Genetic and Pharmacological Targeting of CSF-1/CSF-1R Inhibits Tumor-Associated Macrophages and Impairs BRAF-Induced Thyroid Cancer Progression
    Journal Article

    Ryder, M.; Gild, M.; Hohl, T. M.; Pamer, E.; Knauf, J.; Ghossein, R.; Joyce, J. A.; Fagin, J. A.
    PLoS ONE (2013)

    Fulltext@MSK | Save
  • Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer
    Journal Article

    Ho, A. L.; Grewal, R. K.; Leboeuf, R.; Sherman, E. J.; Pfister, D. G.; Deandreis, D.; Pentlow, K. S.; Zanzonico, P. B.; Haque, S.; Gavane, S.; more...
    New England Journal of Medicine (2013)

    Fulltext@MSK | Save
  • Exomic sequencing of medullary thyroid cancer reveals dominant and mutually exclusive oncogenic mutations in RET and RAS
    Journal Article

    Agrawal, N.; Jiao, Y.; Sausen, M.; Leary, R.; Bettegowda, C.; Roberts, N. J.; Bhan, S.; Ho, A. S.; Khan, Z.; Bishop, J.; more...
    Journal of Clinical Endocrinology and Metabolism (2013)

    Fulltext@MSK | Save
  • A phase II study of temsirolimus/sorafenib in patients with radioactive iodine (RAI)-refractory thyroid carcinoma
    Meeting Abstract

    Sherman, E. J.; Ho, A. L.; Fury, M. G.; Baxi, S. S.; Haque, S.; Korte, S. H.; Smith-Marrone, S.; Xiao, H.; Ghossein, R. A.; Fagin, J. A.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save